160 related articles for article (PubMed ID: 26253380)
1. Long-circulating lipoprotein-mimic nanoparticles for smart intravenous delivery of a practically-insoluble antineoplastic drug: Development, preliminary safety evaluations and preclinical pharmacokinetic studies.
Tadros MI; Al-Mahallawi AM
Int J Pharm; 2015 Sep; 493(1-2):439-50. PubMed ID: 26253380
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion.
Ganta S; Paxton JW; Baguley BC; Garg S
Int J Pharm; 2008 Aug; 360(1-2):115-21. PubMed ID: 18508212
[TBL] [Abstract][Full Text] [Related]
3. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
4. Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles.
Wei Y; Li L; Xi Y; Qian S; Gao Y; Zhang J
Int J Pharm; 2014 Dec; 476(1-2):142-8. PubMed ID: 25269007
[TBL] [Abstract][Full Text] [Related]
5. Spray-Dried Silica Xerogel Nanoparticles as a Promising Gastroretentive Carrier System for the Management of Chemotherapy-Induced Nausea and Vomiting.
Ghoneim AM; Tadros MI; Alaa-Eldin AA
Int J Nanomedicine; 2019; 14():9619-9630. PubMed ID: 31824155
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies.
Bhatta RS; Chandasana H; Chhonker YS; Rathi C; Kumar D; Mitra K; Shukla PK
Int J Pharm; 2012 Aug; 432(1-2):105-12. PubMed ID: 22569234
[TBL] [Abstract][Full Text] [Related]
7. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
8. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
Zhao L; Zhou Y; Gao Y; Ma S; Zhang C; Li J; Wang D; Li X; Li C; Liu Y; Li X
Int J Pharm; 2015 Apr; 483(1-2):180-7. PubMed ID: 25681723
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Evaluation of Cabazitaxel-Loaded Bovine Serum Albumin Nanoparticles for Prostate Cancer.
Wan Z; Xie F; Wang L; Zhang G; Zhang H
Int J Nanomedicine; 2020; 15():5333-5344. PubMed ID: 32801692
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
[TBL] [Abstract][Full Text] [Related]
11. Heparin appended ADH-anionic polysaccharide nanoparticles for site-specific delivery of usnic acid.
Garg A; Garg S; Sahu NK; Rani S; Gupta U; Yadav AK
Int J Pharm; 2019 Feb; 557():238-253. PubMed ID: 30594688
[TBL] [Abstract][Full Text] [Related]
12. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
AAPS PharmSciTech; 2013 Jun; 14(2):782-93. PubMed ID: 23615773
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
14. Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.
Zhang JY; He B; Qu W; Cui Z; Wang YB; Zhang H; Wang JC; Zhang Q
J Microencapsul; 2011; 28(6):528-36. PubMed ID: 21702701
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.
Girotra P; Singh SK
Pharm Res; 2016 Jul; 33(7):1682-95. PubMed ID: 27003706
[TBL] [Abstract][Full Text] [Related]
17. Inducing Controlled Release and Increased Tumor-Targeted Delivery of Chlorambucil via Albumin/Liposome Hybrid Nanoparticles.
Zhang Q; Zhang L; Li Z; Xie X; Gao X; Xu X
AAPS PharmSciTech; 2017 Nov; 18(8):2977-2986. PubMed ID: 28477146
[TBL] [Abstract][Full Text] [Related]
18. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
19. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
[TBL] [Abstract][Full Text] [Related]
20. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
